Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.
about
Intensive leukapheresis in the management of cytopenias in patients with chronic lymphocytic leukaemia (CLL) and lymphocytic lymphoma.Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin.Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill.Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site.Variations in levels of blood clotting factors IX and X in a population of normal men: possible genetic polymorphisms.Factor V anticoagulants: clinical, biochemical, and immunological observationsCross-reacting material in genetic variants of haemophilia BHaemophilia: strategies for carrier detection and prenatal diagnosis.Hereditary disorders of blood coagulation due to defective and deficient synthesis of proteinPurification and characterization of an abnormal factor IX (Christmas factor) molecule. Factor IX Chapel Hill.Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.Identification of the molecular defect in factor IX Chapel Hill: substitution of histidine for arginine at position 145.Polymorphism of normal factor IX detected by mouse monoclonal antibodies.Immunological heterogeneity of haemophilia B: a multicentre study of 98 kindreds.Coagulation factor variants.New methods in coagulation.Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothroA CRM-Positive variant of factor-VII deficiency and the detection of heterozygotes with the assay of factor-like antigen.Active and inactive factor VII in Dubin-Johnson syndrome with factor-VII deficiency, hereditary factor-VII deficiency and on coumadin administration.Detection of genetic variants of haemophilia B with an immunosorbent technique.Studies on Christmas disease: investigation and treatment of a familial acquired inhibitor of factor IX.Molecular deficiencies of human blood coagulation.Factor VIII and IX variants. Relationship between haemophilia B M and haemophilia B+.An agarose plate method for detecting alloantisera to coagulant factor IX and factor IX antigen.Characterization of a variant prothrombin in a patient congenitally deficient in factors II, VII, IX and X.A genetic variant of factor IX with decreased capacity for Ca2+ binding.Immunologic studies of factor IX (Christmas factor). II. Immunoradiometric assay of factor IX antigen.An immunological investigation of hemophilia B with a tentative classification of the disease into five variants.Determination of factor IX allotypes for carrier identification in haemophilia B.Studies on immunological assay of vitamin-K dependent factors. III. A double monoclonal immunoradiometric assay for factor IX antigen.Carrier detection in factor VII congenital deficiency.
P2860
Q33448008-42F3435A-2186-47FB-ABCE-A430FD16293FQ34283513-E27834D7-7C7F-46DB-A29B-71B0D566D6BFQ34521511-0FC516A2-9A47-4778-BDD1-CB38C4EB0689Q34522488-C38BBF62-7510-47B0-9328-DB2C8082EC47Q35569193-972CA610-B3E2-439A-93B8-6471F45FF2BDQ35579514-5B101242-B87F-4547-9A29-3C1CF7EB4A51Q36637083-AB80F3F3-08ED-4E5C-A950-02D733FE089AQ36669776-E08E97A5-63DE-435E-BB7D-45F2CE60D679Q36738544-EAF0FBBC-EB26-4DE3-A620-F59EEDB7254DQ37033453-6CE66526-8CDF-4E78-BEC3-A2FB55DEB33EQ37044413-32A0FA55-4ED7-4245-A1B8-8FEA5B64D029Q37341414-AF54866E-FFE3-425B-8B6B-63A121D33972Q37690519-CAD3B7CA-4DCD-409D-9241-8144115E141CQ39638488-A9EBD2BE-45C1-4707-8018-8FDABF18BE56Q39921747-BA738F61-49D4-4382-AF5E-4955C9DC0D13Q40219568-51DAF75B-29DE-4A47-B9AF-DDB581ECAF6FQ41999331-F9D634DE-6847-4B7A-9FFC-B099E1A19A5CQ43428847-E7A765B1-17D3-43EC-BCFA-7F37D20ADFF4Q43644299-5148A3D7-16A3-4A1E-96DD-94DE3BCDF3F5Q45856433-15214E1E-4401-482A-AB9A-3C2ABC5B48EFQ45856897-379D122F-930A-488C-A8A3-50979059590BQ45856964-6F0C926D-9606-45CD-9127-E0D605757471Q45857321-871C2483-20E1-4B6F-95F2-15A2190A39ABQ45865595-79238969-DCBE-4AB8-8014-130D151F8532Q45865599-D8995945-E664-464E-98EE-DC9F9B1D0CEEQ45876785-64D038F2-63C0-4AC1-8986-5925FD521B37Q45877216-0BA18792-6D10-475D-8CE7-6069D93A445BQ45877523-687BF149-6850-459D-BA9A-813EC14153BBQ45888644-BB68D493-4ADD-402F-9007-515E8097797BQ45888860-D37BCC1D-16A4-479E-B413-4FA08AA1ED14Q49246582-94CBC989-B8A6-4645-8226-3A3F2D5D0334
P2860
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.
description
1968 nî lūn-bûn
@nan
1968 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1968 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1968年の論文
@ja
1968年論文
@yue
1968年論文
@zh-hant
1968年論文
@zh-hk
1968年論文
@zh-mo
1968年論文
@zh-tw
1968年论文
@wuu
name
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.
@ast
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.
@en
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.
@nl
type
label
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.
@ast
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.
@en
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.
@nl
prefLabel
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.
@ast
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.
@en
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.
@nl
P2093
P2860
P356
P1476
Genetic variants of hemophilia B: detection by means of a specific PTC inhibitor.
@en
P2093
G D Penick
H R Roberts
J E Grizzle
W D McLester
P2860
P304
P356
10.1172/JCI105732
P407
P577
1968-02-01T00:00:00Z